跳至主要内容
临床试验/NCT01515397
NCT01515397已完成3 期

Efficacy and Safety of a Balanced Gelatine Solution in Combination With a Balanced Electrolyte Solution Versus a Standard Gelatine Solution in Combination With a Non-balanced Electrolyte Solution in Patients Scheduled for Abdominal Surgery

B. Braun Melsungen AG2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
40
试验地点
2
主要终点
base excess [mmol/l]

研究概览

简要总结

The aim of volume replacement is to compensate a reduction in the intravascular volume e.g. during surgery and to counteract hypovolemia in order to maintain hemodynamics and vital functions. To achieve this, different plasma substitutes are available: Albumin, dextran, hydroxyethylstarches and gelatine. The aim of this study is to demonstrate that acid-base alterations during elective abdominal surgery can be reduced by the use of a new gelatine solution.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

balanced gelatine solution

Experimental

isotonic colloidal volume substitute

干预措施: Gelofusine balanced (Drug)

non-balanced gelatine solution

Active Comparator

colloidal volume substitute

干预措施: Gelofusine 4% (Drug)

结局指标

主要结局

base excess [mmol/l]

时间窗: Change from baseline at end of surgery, an expected average of 2 hours surgery

chloride [mmol/l]

时间窗: Change from baseline at end of surgery, an expected average of 2 hours surgery

次要结局

  • arterial blood gase analyses(until 12 hours after surgery)
  • coagulation status(until 12 hours after surgery)
  • renal function(until 12 hours after surgery)
  • adverse events(until 12 hours after surgery)
  • hemodynamics (systolic and diastolic blood pressure)(until 12 hours after surgery)
  • time on ventilation(until 12 hours after surgery)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Comparison of Two Gelatine Solutions | 临床试验